In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

James R. Shoblock; Natalie Welty; Diane Nepomuceno; Brian Lord; Leah Aluisio; Ian Fraser; S. Timothy Motley; Steve W. Sutton; Kirsten Morton; Ruggero Galici; John R. Atack; Lisa Dvorak; Devin M. Swanson; Nicholas I. Carruthers; Curt Dvorak; Timothy W. Lovenberg; Pascal Bonaventure